NCT04939753View on ClinicalTrials.gov

Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the ICU: a Retrospective Analysis

CompletedOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions

Nephrogenic Diabetes Insipidus

Interventions

DRUG

Sevoflurane

Sevoflurane administration to sedate the patient

Trial Locations (1)

1090

UZ Brussel, Jette

All Listed Sponsors

lead

Universitair Ziekenhuis Brussel

OTHER